Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
4.71
-0.05 (-1.05%)
At close: Jun 27, 2025, 3:59 PM
4.78
1.49%
After-hours: Jun 27, 2025, 04:04 PM EDT
Avalo Therapeutics Revenue
Avalo Therapeutics reported an annual revenue of $441K, reflecting a -77.08% growth. For the quarter ending March 31, 2025, Avalo Therapeutics generated $0 in revenue.
Revenue (ttm)
$441K
Revenue Growth
-77.08%
Price / Sales Ratio
136.95
Revenue / Employee
$19.17K
Employees
23
Market Cap
51M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|